The impact of COVID-19 on research

      Coronavirus disease 2019 (COVID-19) has swept across the globe causing hundreds of thousands of deaths, shutting down economies, closing borders and wreaking havoc on an unprecedented scale. It has strained healthcare services and personnel to the brink in many regions and will certainly deeply mark medical research both in the short and long-term.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • NIH
        Estimates of funding for various research, condition, and disease categories (RCDC).
        February 2020
      1. European Commission. Press release. May 2020.

        • Mehra M.R.
        • Desai S.S.
        • Ruschitzka F.
        • Patel A.N.
        Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
        Lancet. 2020; S0140–6736 ([published online ahead of print, 2020 May 22] [published correction appears in Lancet. 2020 May 30;:]): 31180-31186
        • Mehra M.R.
        • Desai S.S.
        • Kuy S.
        • Henry T.D.
        • Patel A.N.
        Retraction: cardiovascular disease, drug therapy, and mortality in covid-19.
        N Engl J Med. 2020; 382 ([retraction of: N Engl J Med. 2020 Jun 18;382(25):e102]): 2582https://doi.org/10.1056/NEJMoa2007621
      2. The pandemic claims new victims: prestigious medical journals. New York Times, June 2020.

        • Yazdany J.
        • Kim A.H.J.
        Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know.
        Ann Intern Med. 2020; 172: 754-755
      3. Statement from the chief investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine, 5 June 2020.

        • Dorn A.V.
        • Cooney R.E.
        • Sabin M.L.
        COVID-19 exacerbating inequalities in the US.
        Lancet. 2020; 395: 1243-1244
        • Vincent-Lamarre P.
        • Sugimoto C.R.
        • Larivière V.
        The decline of women’s research production during the coronavirus pandemic.
        Nature Index. 19 May 2020;
        • Upadhaya S.
        • Yu J.X.
        • Oliva C.
        • Hoton M.
        • Hodge J.
        • Hubbard-Lucey V.M.
        Impact of COVID-19 on oncology clinical trials.
        Nat Rev Drug Discov. 2020; 19: 376-377
        • Webster P.
        How is biomedical research funding faring during the COVID-19 lockdown?.
        Nat Med. April 2020; ([published online ahead of print, 2020 Apr 16])https://doi.org/10.1038/d41591-020-00010-4
        • Rosenbaum L.
        The untold toll - the pandemic's effects on patients without covid-19.
        N Engl J Med. 2020; https://doi.org/10.1056/NEJMms2009984
        • Stephenson J.
        Sharp drop in routine vaccinations for US children amid COVID-19 pandemic.
        JAMA Health Forum. 2020; 1e200608
        • United Nations policy brief
        The impact of Covid-19 on children.
        16th April, 2020
        • Boyle B.
        • Addor M.C.
        • Arriola L.
        • Barisic I.
        • Bianchi F.
        • Csaki-Szunyogh M.
        • et al.
        Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data.
        Arch Dis Child Fetal Neonatal Ed. 2018; 103: F22-F28